PacBio's Q1 Revenues Sink 44 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Pacific Biosciences reported after the close of the market Tuesday that its first-quarter 2013 revenues dropped 44 percent year over year and 5 percent sequentially.

The Menlo Park, Calif.-based single molecule sequencing technologies firm reported total revenues of $5.6 million for the three months ended March 31, compared to $10 million for the first quarter of 2012 and $5.9 million for the last quarter of 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.